Abstract:Background: Prematurity is a leading cause of neonatal morbidity and mortality and is associated with insufficient development of multiple body structures, including neurovascular and retinal tissues. Retinopathy of prematurity (ROP) is an abnormal vaso proliferation of the neonatal retina that results from an arrest in the normal development of the retinal nerve and blood supply. Incidence has been increasing due to advancements in intensive care and survival of preterm neonates, as well as improvements in sc… Show more
“…4 The prevalence of patients diagnosed with ROP was 37.3%, which is relatively similar to that reported by Al-Qahtani et al in 2019 but substantially lower than the proportion discovered in the 2008 study by Binkhathlan et al Both preterm eyes had a stage 1 predominance, with 18 in the right eye and 21 in the left eye, respectively. 7 We found similar results in our study: the prevalence was stage 1 (46. %), and a unilateral eye affection by (73.3%).…”
Section: Discussionsupporting
confidence: 90%
“…The International Classification for ROP (ICROP) was established in 1984. According to the zones of the retina affected by the illness (1, 2, and 3), the extent of the disease as measured by clock hours (1)(2)(3)(4)(5)(6)(7)(8)(9)(10)(11)(12), and the severity of the disease as measured by different stages (0-5), the ROP is categorized. 4 Moreover, a demarcation line, ridge with height and width, proliferation of fibrovascular cells in extra retinal tissue, partial retinal detachment, and total retinal detachment are the five phases of ROP.…”
Section: Introductionmentioning
confidence: 99%
“…The study showed a 51.4% female predominance, a mean gestational age of 27 weeks, a mean birth weight of 800 g, birth weight, and the development of ROP in the right eye were significantly correlated, as were gestational age and the development of ROP in the same eye, and 66.7% of infants who developed ROP were delivered by cesarean section. 7 Lastly, a cohort review was conducted in King Abdulaziz Medical City, Riyadh, Saudi Arabia, from 2010 to 2014, with a total of 581 newly enrolled patients. A total of 224 newborns (38.6%) had ROP, and 22 (10.4%) had stage 3 ROP.…”
Background Premature newborns are susceptible to retinopathy of prematurity (ROP), a vasoproliferative disease of the developing retinal vessels, which is a major cause of potentially avoidable blindness. Due to geographical variations in newborn care, geographic variations in the epidemiology of ROP have been observed internationally during the last several decades. There was a correlation between the severity of the condition and the number of prenatal, postnatal, and other risk factors. This study aimed to examine the incidence and risk factors associated with retinopathy of prematurity in preterm infants. Methods A retrospective review of preterm newborns evaluated for retinopathy of prematurity between January 2016 and December 2022 was carried out at King Fahd Hospital of the University (KFHU), Khobar, Saudi Arabia. Infants who fulfilled the screening criteria (GA < 34 or Birth Weight (WT) ≤ 1500 g) underwent the screening test, and the International Classification of Retinopathy of Prematurity was used to classify retinopathy of prematurity. Risk factors and demographic information regarding ROP were assessed. Statistical analysis was performed using SPSS (version 20) with a 95% confidence interval (CI). Statistical significance was set at p < 0.05. Results Among the 200 preterm neonates that were evaluated and admitted to neonatal critical care units, 37% exhibited premature retinopathy, with 46.7% of those cases being in stage 1. The development of ROP was linked to gestational age, length of mechanical ventilation, septicemia, intraventricular hemorrhage, bronchopulmonary dysplasia, respiratory distress syndrome, and septicemia, according to univariate and multivariate logistic regression analyses. Conclusion The incidence of total retinopathy in premature infants in this population was 37%. Evaluating these risk factors during the screening of high-risk premature infants will help determine the appropriate timing of examinations and treatment.
“…4 The prevalence of patients diagnosed with ROP was 37.3%, which is relatively similar to that reported by Al-Qahtani et al in 2019 but substantially lower than the proportion discovered in the 2008 study by Binkhathlan et al Both preterm eyes had a stage 1 predominance, with 18 in the right eye and 21 in the left eye, respectively. 7 We found similar results in our study: the prevalence was stage 1 (46. %), and a unilateral eye affection by (73.3%).…”
Section: Discussionsupporting
confidence: 90%
“…The International Classification for ROP (ICROP) was established in 1984. According to the zones of the retina affected by the illness (1, 2, and 3), the extent of the disease as measured by clock hours (1)(2)(3)(4)(5)(6)(7)(8)(9)(10)(11)(12), and the severity of the disease as measured by different stages (0-5), the ROP is categorized. 4 Moreover, a demarcation line, ridge with height and width, proliferation of fibrovascular cells in extra retinal tissue, partial retinal detachment, and total retinal detachment are the five phases of ROP.…”
Section: Introductionmentioning
confidence: 99%
“…The study showed a 51.4% female predominance, a mean gestational age of 27 weeks, a mean birth weight of 800 g, birth weight, and the development of ROP in the right eye were significantly correlated, as were gestational age and the development of ROP in the same eye, and 66.7% of infants who developed ROP were delivered by cesarean section. 7 Lastly, a cohort review was conducted in King Abdulaziz Medical City, Riyadh, Saudi Arabia, from 2010 to 2014, with a total of 581 newly enrolled patients. A total of 224 newborns (38.6%) had ROP, and 22 (10.4%) had stage 3 ROP.…”
Background Premature newborns are susceptible to retinopathy of prematurity (ROP), a vasoproliferative disease of the developing retinal vessels, which is a major cause of potentially avoidable blindness. Due to geographical variations in newborn care, geographic variations in the epidemiology of ROP have been observed internationally during the last several decades. There was a correlation between the severity of the condition and the number of prenatal, postnatal, and other risk factors. This study aimed to examine the incidence and risk factors associated with retinopathy of prematurity in preterm infants. Methods A retrospective review of preterm newborns evaluated for retinopathy of prematurity between January 2016 and December 2022 was carried out at King Fahd Hospital of the University (KFHU), Khobar, Saudi Arabia. Infants who fulfilled the screening criteria (GA < 34 or Birth Weight (WT) ≤ 1500 g) underwent the screening test, and the International Classification of Retinopathy of Prematurity was used to classify retinopathy of prematurity. Risk factors and demographic information regarding ROP were assessed. Statistical analysis was performed using SPSS (version 20) with a 95% confidence interval (CI). Statistical significance was set at p < 0.05. Results Among the 200 preterm neonates that were evaluated and admitted to neonatal critical care units, 37% exhibited premature retinopathy, with 46.7% of those cases being in stage 1. The development of ROP was linked to gestational age, length of mechanical ventilation, septicemia, intraventricular hemorrhage, bronchopulmonary dysplasia, respiratory distress syndrome, and septicemia, according to univariate and multivariate logistic regression analyses. Conclusion The incidence of total retinopathy in premature infants in this population was 37%. Evaluating these risk factors during the screening of high-risk premature infants will help determine the appropriate timing of examinations and treatment.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.